"The Luminare Studies are evaluating the safety and efficacy of a study drug, as compared to a placebo, to see if it may delay the progression of Parkinson’s disease in people who are in the early stage of their condition. "
"The Luminare Studies include 2 individual studies, LUMA and LIGHTHOUSE. They are both evaluating the same study drug but each study has different criteria to participate. All study participants will receive genetic testing at the beginning of the study (at no cost). The outcome of the genetic test will determine, among other factors, whether you may qualify for LUMA or LIGHTHOUSE."
parkinsonsresearchstudies.c...
------------------------------------------------------